Desensitization in kidney transplantation: review and future perspectives. - Wikidata - wikimedia - TriplyDB

Desensitization in kidney transplantation: review and future perspectives.

Desensitization in kidney transplantation: review and future perspectives.

http://www.wikidata.org/entity/Q38195324

about

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation.Antibody-Mediated Rejection: A Review.Kidney transplantation in highly sensitized patients.The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates.Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome.A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease.Protein a Immunoadsorption May Hamper the Decision to Transplant Due to Interference With CDC Crossmatch Results.Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner.Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.Effect of infusion of monoclonal antibodies to tumour necrosis factor-receptor super family 25 on graft rejection in allo-immune mice receiving autologous marrow transplantation.

P2860

Q30276550-9C33BDFE-466F-4B2D-A161-8BF4E7A7E6E1 Q33853510-25B6699F-7494-4E3D-884E-EB2D8FAF5CA3 Q37698860-7B92BB4B-28C6-4D6C-9C09-6C7E0F64C982 Q38455229-AB13A1F6-6D76-4018-92F3-C28E3E047D3E Q38726037-360E3A26-D70C-4682-BFBF-ED9A7D8B9AA1 Q42181436-9C832CEE-63D3-4A3C-8A9B-9C1C993CC09F Q47130649-39A00B2F-3A61-4CA9-A9B4-7EAB9AD9D202 Q47593297-1A6EB785-6991-486E-A497-170A34EEB503 Q47779198-4A16700A-D41E-4919-AC63-002AA9925EEB Q48112929-5EAE3420-B5BE-41CF-B0EF-A49737CFB0D5 Q48300620-7520C77C-E3B5-40D0-8C77-044A9412B21A Q51320634-E771413F-44C9-4590-8CF4-26638C60EE96

P2860

Desensitization in kidney transplantation: review and future perspectives.

http://www.wikidata.org/entity/Q38195324

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Desensitization in kidney transplantation: review and future perspectives.

@en

type

label

Desensitization in kidney transplantation: review and future perspectives.

@en

prefLabel

Desensitization in kidney transplantation: review and future perspectives.

@en

P1433

Q38195324-92596D72-D870-457A-8415-F607F430CA9B

P1476

Q38195324-F4D75E69-2160-4DF5-92DC-D2A65BADD00C

P2093

Q38195324-27F4B0E4-1170-4D60-A5AB-AF564B7276E6

Q38195324-6EC3B88A-B40C-4C32-8F5E-5D0D3C79B77B

Q38195324-B4B431BE-633B-492B-B4F3-35DF5596A404

Q38195324-C932E4CD-D918-4E38-AC46-443F08B42517

Q38195324-EB5849DF-85AA-44AE-909E-CED45AC677A4

P2860

Q38195324-0626CD86-39FC-4D27-AC5D-2BF4F113B1B9

Q38195324-0A1FF6EB-D774-4CD3-A7DA-6FCAC7C3944B

Q38195324-13C12E39-75AB-4202-B240-C1A9473929DD

Q38195324-25FE2F50-E704-4B12-B719-E4579640A888

Q38195324-29C3FB64-026A-4EFA-8DE4-5894FAA423FC

Q38195324-2D52150A-C52B-4C03-9BE3-59EFD927C9C2

Q38195324-33E06E86-4A1E-407D-87B9-19B2F404D89A

Q38195324-3993AD94-B6EC-4383-AC09-1B7713058DA6

Q38195324-406B2BD1-99A2-4609-A995-ADC0BA422272

Q38195324-46DBE7DF-616E-425C-B586-5BB4AED8014F

P304

Q38195324-8F82A4E8-EDA9-486F-A838-6924C487002D

P31

Q38195324-80E67CB2-E225-453A-9B5E-647A3A8BA2B9

P356

Q38195324-5490FE56-765F-459E-B305-A4C6046F9206

P433

Q38195324-801CEFB7-D115-40FE-9F72-A5BAC7488A37

P478

Q38195324-F54FF04F-D0BC-41D1-B525-5E0D822F9DAC

P577

Q38195324-A42ACFFC-F6D3-4220-ABE5-E12BC9D7D98E

P698

Q38195324-83BEF28A-44EA-4B17-9FFA-0A726DA71BFF

P356

P1433

Clinical Transplantation

P1476

Desensitization in kidney transplantation: review and future perspectives.

@en

P2093

Adele Rike Shields

http://www.w3.org/2001/XMLSchema#string

Bassam G Abu Jawdeh

http://www.w3.org/2001/XMLSchema#string

E Steve Woodle

http://www.w3.org/2001/XMLSchema#string

Madison C Cuffy

http://www.w3.org/2001/XMLSchema#string

Rita R Alloway

http://www.w3.org/2001/XMLSchema#string

P2860

PLASMAPHERESIS IN THE MANAGEMENT OF ACUTE SYSTEMIC LUPUS ERYTHEMATOSUS?

Introduction and overview of therapeutic apheresis.

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

The proteasome: structure, function, and role in the cell.

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates

Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients.

P304

494-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CTR.12335

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24621089

http://www.w3.org/2001/XMLSchema#string